Ownership

Helen Torley - PRESIDENT AND CEO, Director at Halozyme Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type: Individual
Role: PRESIDENT AND CEO, Director
Stock Symbol: HALO on Nasdaq
Industry: Biological Products, (No Diagnostic Substances)
All Insider Reports: All Insider Reports

Helen Torley - trading volume in the past year for Halozyme Therapeutics, Inc.

	Shares	%	Avg Price	Total $
Buys
Sells	-110K	100%	$56.91	-$6.26M
Net	-110K	-100%		-$6.26M

Holdings reported by Helen Torley for Halozyme Therapeutics, Inc.

Class	Num Shares	Value	Price $	Transaction Date	Ownership	Underlying Class	Underlying Amount
Common Stock	677K	$36.5M	$53.91	Oct 9, 2024	Direct
Restricted Stock Units	89.7K	$3.24M	$36.10	Feb 23, 2024	Direct	Common Stock
Option to Purchase Common Stock	93K	$1.29M	$13.87	Feb 23, 2024	Direct	Common Stock
Option to Purchase Common Stock	0	$0	$13.87	Oct 9, 2024	Direct	Common Stock

Transactions reported by Helen Torley for Halozyme Therapeutics, Inc.

Sym	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.